Terminated NA INTERVENTIONAL 3-arm NCT00981929

Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes

Sponsor: Odense University Hospital

Conditions Cytochrome P450 Phenotype and Genotype Metrics

Interventions Omeprazole, losartan, caffeine Tramadol Tramadol, omeprazole, losartan, caffeine

Updated 5 times since 2017 Last updated: Jun 24, 2010 Started: Sep 30, 2009 Primary completion: Dec 31, 2009 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unexpected non-serious adverse events

Other terminated trials from Odense University Hospital

See all terminations from Odense University Hospital

Listed as NCT00981929, this NA trial focuses on Cytochrome P450 Phenotype and Genotype Metrics and remains terminated or withdrawn. Sponsored by Odense University Hospital, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Odense University Hospital
University of Southern Denmark

Data source: University of Southern Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Odense, Denmark